Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMYMP) Goodwill (2016 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed Goodwill for 17 consecutive years, with $21.8 billion as the latest value for Q4 2025.

  • Quarterly Goodwill changed 0.16% to $21.8 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $21.8 billion through Dec 2025, changed 0.16% year-over-year, with the annual reading at $21.8 billion for FY2025, 0.16% changed from the prior year.
  • Goodwill for Q4 2025 was $21.8 billion at Bristol Myers Squibb, roughly flat from $21.7 billion in the prior quarter.
  • The five-year high for Goodwill was $21.8 billion in Q2 2025, with the low at $20.4 billion in Q2 2022.
  • Average Goodwill over 5 years is $21.2 billion, with a median of $21.2 billion recorded in 2023.
  • The sharpest move saw Goodwill fell 8.59% in 2021, then rose 3.51% in 2023.
  • Over 5 years, Goodwill stood at $20.5 billion in 2021, then rose by 3.16% to $21.1 billion in 2022, then grew by 0.09% to $21.2 billion in 2023, then rose by 2.6% to $21.7 billion in 2024, then increased by 0.16% to $21.8 billion in 2025.
  • According to Business Quant data, Goodwill over the past three periods came in at $21.8 billion, $21.7 billion, and $21.8 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.